These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14610192)

  • 21. Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase.
    Tonks NK; Charbonneau H; Diltz CD; Fischer EH; Walsh KA
    Biochemistry; 1988 Nov; 27(24):8695-701. PubMed ID: 2853967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major histocompatibility complex class-II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane.
    Finzi A; Perlman M; Bourgeois-Daigneault MC; Thibodeau J; Cohen ÉA
    Cell Microbiol; 2013 May; 15(5):809-22. PubMed ID: 23170932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responses.
    Leith JG; Clark DA; Matthews TJ; Rosenthal KL; Luscher MA; Barber BH; MacDonald KS
    AIDS Res Hum Retroviruses; 2003 Nov; 19(11):957-65. PubMed ID: 14678602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis.
    Schols D; Pauwels R; Desmyter J; De Clercq E
    Virology; 1992 Jul; 189(1):374-6. PubMed ID: 1604822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression and incorporation of GagPol precursor does not impede packaging of HIV-1 tRNA(Lys3) but promotes intracellular budding of virus-like particles.
    Shehu-Xhilaga M; Lee JY; Campbell S; Marshall JA; Crowe SM; Mak J
    J Biomed Sci; 2002; 9(6 Pt 2):697-705. PubMed ID: 12432236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonrandom association of cellular antigens with HTLV-III virions.
    Hoxie JA; Fitzharris TP; Youngbar PR; Matthews DM; Rackowski JL; Radka SF
    Hum Immunol; 1987 Jan; 18(1):39-52. PubMed ID: 3542913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dense Array of Spikes on HIV-1 Virion Particles.
    Stano A; Leaman DP; Kim AS; Zhang L; Autin L; Ingale J; Gift SK; Truong J; Wyatt RT; Olson AJ; Zwick MB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of immunogenic HIV-1 viruslike particles in stably engineered monkey cell lines.
    Haynes JR; Cao SX; Rovinski B; Sia C; James O; Dekaban GA; Klein MH
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):17-27. PubMed ID: 1707639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies.
    Poignard P; Moulard M; Golez E; Vivona V; Franti M; Venturini S; Wang M; Parren PW; Burton DR
    J Virol; 2003 Jan; 77(1):353-65. PubMed ID: 12477840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
    Shehu-Xhilaga M; Hill M; Marshall JA; Kappes J; Crowe SM; Mak J
    J Virol; 2002 May; 76(9):4331-40. PubMed ID: 11932399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells.
    Strauss JD; Hammonds JE; Yi H; Ding L; Spearman P; Wright ER
    J Virol; 2016 Feb; 90(3):1507-21. PubMed ID: 26582000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.
    Holm GH; Gabuzda D
    J Virol; 2005 May; 79(10):6299-311. PubMed ID: 15858014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.
    Burrer R; Haessig-Einius S; Aubertin AM; Moog C
    J Virol; 2003 Nov; 77(21):11385-97. PubMed ID: 14557624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human macrophages accumulate HIV-1 particles in MHC II compartments.
    Raposo G; Moore M; Innes D; Leijendekker R; Leigh-Brown A; Benaroch P; Geuze H
    Traffic; 2002 Oct; 3(10):718-29. PubMed ID: 12230470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CIITA enhances HIV-1 attachment to CD4+ T cells leading to enhanced infection and cell depletion.
    Porter KA; Kelley LN; Nekorchuk MD; Jones JH; Hahn AB; de Noronha CM; Harton JA; Duus KM
    J Immunol; 2010 Dec; 185(11):6480-8. PubMed ID: 21041720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study.
    Meerloo T; Sheikh MA; Bloem AC; de Ronde A; Schutten M; van Els CA; Roholl PJ; Joling P; Goudsmit J; Schuurman HJ
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():129-35. PubMed ID: 8093711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography.
    Richieri SP; Bartholomew R; Aloia RC; Savary J; Gore R; Holt J; Ferre F; Musil R; Tian HR; Trauger R; Lowry P; Jensen F; Carlo DJ; Maigetter RZ; Prior CP
    Vaccine; 1998; 16(2-3):119-29. PubMed ID: 9607019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.
    Saifuddin M; Parker CJ; Peeples ME; Gorny MK; Zolla-Pazner S; Ghassemi M; Rooney IA; Atkinson JP; Spear GT
    J Exp Med; 1995 Aug; 182(2):501-9. PubMed ID: 7543140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.